What’s in Sientra, Inc. (SIEN) After Today’s Significant Increase?

February 15, 2018 - By Ellis Scott

Investors sentiment decreased to 1.52 in Q3 2017. Its down 0.34, from 1.86 in 2017Q2. It dived, as 9 investors sold Sientra, Inc. shares while 14 reduced holdings. 13 funds opened positions while 22 raised stakes. 14.36 million shares or 1.78% more from 14.11 million shares in 2017Q2 were reported.
Ameriprise Fincl Incorporated has invested 0% of its portfolio in Sientra, Inc. (NASDAQ:SIEN). Moreover, Eam Ltd Liability has 0.4% invested in Sientra, Inc. (NASDAQ:SIEN) for 195,989 shares. Weiss Multi reported 10,000 shares or 0.01% of all its holdings. Nationwide Fund Advsr holds 0% of its portfolio in Sientra, Inc. (NASDAQ:SIEN) for 7,921 shares. Deutsche Savings Bank Ag has invested 0% in Sientra, Inc. (NASDAQ:SIEN). Bamco Ny owns 501,500 shares. Renaissance Technologies Ltd Liability Company reported 171,700 shares stake. Tower Research Cap Ltd Liability Corp (Trc) holds 0% of its portfolio in Sientra, Inc. (NASDAQ:SIEN) for 2,339 shares. Atika Capital Management Llc stated it has 220,000 shares or 0.97% of all its holdings. Pura Vida Limited owns 1.45% invested in Sientra, Inc. (NASDAQ:SIEN) for 187,800 shares. Moreover, International Group has 0% invested in Sientra, Inc. (NASDAQ:SIEN). Clarus Ventures Limited accumulated 2.73M shares. Wells Fargo Mn accumulated 22,903 shares or 0% of the stock. Blair William & Communication Il holds 70,813 shares or 0.01% of its portfolio. State Street reported 0% of its portfolio in Sientra, Inc. (NASDAQ:SIEN).

The stock of Sientra, Inc. (NASDAQ:SIEN) is a huge mover today! The stock increased 3.59% or $0.39 during the last trading session, reaching $11.24. About 127,260 shares traded. Sientra, Inc. (NASDAQ:SIEN) has risen 27.61% since February 15, 2017 and is uptrending. It has outperformed by 10.91% the S&P500.
The move comes after 5 months positive chart setup for the $218.08 million company. It was reported on Feb, 15 by Barchart.com. We have $12.25 PT which if reached, will make NASDAQ:SIEN worth $19.63 million more.

Analysts await Sientra, Inc. (NASDAQ:SIEN) to report earnings on March, 13. They expect $-0.68 earnings per share, down 58.14 % or $0.25 from last year’s $-0.43 per share. After $-0.74 actual earnings per share reported by Sientra, Inc. for the previous quarter, Wall Street now forecasts -8.11 % EPS growth.

Sientra, Inc. (NASDAQ:SIEN) Ratings Coverage

Among 5 analysts covering Sientra (NASDAQ:SIEN), 5 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Sientra had 12 analyst reports since August 14, 2015 according to SRatingsIntel. Stifel Nicolaus maintained it with “Hold” rating and $14.0 target in Tuesday, September 26 report. The company was reinitiated on Thursday, February 11 by Stifel Nicolaus. Canaccord Genuity maintained Sientra, Inc. (NASDAQ:SIEN) rating on Sunday, October 8. Canaccord Genuity has “Buy” rating and $14.0 target. The stock of Sientra, Inc. (NASDAQ:SIEN) has “Buy” rating given on Thursday, January 4 by Canaccord Genuity. The stock of Sientra, Inc. (NASDAQ:SIEN) earned “Hold” rating by Stifel Nicolaus on Wednesday, August 9. Canaccord Genuity maintained the stock with “Buy” rating in Tuesday, October 17 report. As per Friday, January 19, the company rating was upgraded by Stifel Nicolaus. The rating was reinitiated by William Blair with “Market Perform” on Wednesday, August 10. William Blair upgraded the shares of SIEN in report on Wednesday, September 13 to “Outperform” rating. The firm has “Buy” rating given on Monday, August 28 by Canaccord Genuity.

More recent Sientra, Inc. (NASDAQ:SIEN) news were published by: Globenewswire.com which released: “Sientra Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)” on January 25, 2018. Also Globenewswire.com published the news titled: “Sientra® Provides Update on FDA Review of US Manufacturing Facility” on January 30, 2018. Globenewswire.com‘s news article titled: “Lubrizol Customer, Sientra, Inc., Receives FDA Approval to Manufacture Breast …” with publication date: February 06, 2018 was also an interesting one.

Sientra, Inc., a medical aesthetics company, develops and sells medical aesthetics products to plastic surgeons in the United States. The company has market cap of $218.08 million. The firm offers silicone gel breast implants for use in breast augmentation and breast reconstruction procedures; and breast tissue expanders. It currently has negative earnings. It also provides body contouring products; facial and nasal implants; scar management products under the bioCorneum and Silishield brand names; saline-filled breast implant sizers to identify the correct style and size of implants; and non-breast tissue expanders for expanding tissue and skin surface area for burn care and other reconstructive use.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter: